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Abstract
The microcirculation is anatomical and consists of arterioles, capillaries, and venules that 
perform metabolic requirements and oxygen distribution to the tissues. During physi-
ological or pathological stress, it balances between the oxygen delivery and the demand. 
This delicate balance can play an important role in the progression of critical illnesses 
and has a role in the development of organ dysfunction. Reduced microvascular perfu-
sion is seen in many diseases, and hyperbaric oxygen treatment (HBOT) has potentially 
beneficial effects on the microcirculatory environment. It has been shown that HBOT 
improves microcirculation independent from systemic hemodynamic parameters, which 
is a key therapeutic target in the critically ill patient. HBOT is emerging as an adjunct to 
traditional surgery and antibiotic therapy for the special kinds of problematic wounds or 
purpura fulminans, which are caused by meningococcal sepsis. HBOT also can increase 
oxygen supply to the ischemic tissue to reduce the extent of irreversible tissue damage in 
ischemic stroke, femoral head necrosis, diabetic foot ulcer, and carbon monoxide intoxi-
cation. In this chapter, we aim to describe microcirculation with its monitoring systems 
and to show the effectiveness of HBOT in different clinical settings, which are related to 
microcirculatory dysfunction.
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1. Microcirculation physiology
The area of the circulation system where the metabolic requirements of tissues are met is 
called microcirculation. In other words, this is the point at which the arterial system and 
venous system join.
As a result of 6–8 branches occurring in the arterial structure entering a tissue, the width of 
the interior lumen reduces to 10–15 μm, and this structure is called an arteriole. The wall 
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structures of arterioles continue with metarterioles within the continuous surrounding 
smooth muscle, and capillary veins form from metarterioles. At the point where the capillar-
ies emerge from the metarterioles, smooth muscle tissue forms a sphincter-like structure at 
the capillary entrance. Capillary structures continue to form venules. Venules have the larger 
diameter compared to arterioles though they have less muscle tissue. However, less muscle 
tissue causes low pressure within the venule and ensures severe contractile force (Figure 1).
The total wall thickness of capillary structures is 0.5 μm. Shaped elements in the blood can 
only pass through by friction along the wall of the 9-μm lumen. There are openings of 6–7 nm 
width between the endothelial cells of the capillaries called fenestrations. These structures 
form 1/1000 of the total endothelial surface area but are areas where the transfer of water and 
water-soluble material occurs. These fenestrations may differ from organ to organ. These gaps 
are very narrow in the brain, while in the kidneys broad intervals ensure the necessary width 
for glomerular filtration of water and solutes [1].
Capillaries are not continuously open structures. The number of open capillaries varies depend-
ing on the requirements of the tissue, and here the most important stimulus is the oxygen 
Figure 1. The area of the circulation system.
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requirement of the tissue. The precapillary sphincter found at the junction of the metarterioles 
with capillaries plays a role in the opening of closed capillaries and closure of open capillaries, 
and this local control is called vasomotion [2].
There may be nearly 12 l of fluid found in the interstitial area. This cavity found between cells 
is kept open by collagen fibres. Proteoglycans appear to be like a brush for the interstitium. 
Due to proteoglycans found in the interstitial fluid, it has a gel consistency. Water and electro-
lytes may rapidly diffuse within the gel. Free fluid is only found in collagen fibres and at cell 
boundaries in the interstitial area.
The size of exchange areas for material transfer between compartments in the microcircu-
latory environment is directly related to the transfer amounts. Additionally, other effective 
factors are fixed transfer, the presence of membrane carriers, channel-dependent transport, 
barrier permeability, and soluble material transfer [3].
According to Fick’s first law, the solute transfer from a membrane only occurs in situations 
with concentration differences until concentration balance is achieved [4].
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 is the solute flow rate, P
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 is the diffusion permeability constant, and ΔC is the con-
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 is the free diffusion constant, and Δx is the barrier thickness.
According to Fick’s second law, the amount of diffusion is linked to the thickness of the mem-
brane, the surface area over which diffusion occurs, molecular mass and size.
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About 97% of oxygen is bound to haemoglobin in blood and passes into tissues according 
to the Fick law. Oxygen presentation to tissues is dependent on the cardiac output and 
arterial oxygen content. Formula of arterial oxygen content is the sum of the multiplication 
of oxygen saturation, blood haemoglobin level and Hüfner number (amount of oxygen 
carried if haemoglobin is fully filled) with the multiplication of partial oxygen pressure 
by 0.003. There is 100 mmHg oxygen pressure at the arterial tip at the 1 atmospheric pres-
sure while at the pressure of 3 atmospheres with 100% oxygen it increases according to 
the Henry law and reaches to the 2000 mmHg. Tissue oxygen pressure reaches from 55 to 
500 mmHg at this point. At 1 atmosphere pressure, there is 3 ml per litre of free oxygen, and 
this amount reaches 60 ml where the tissues fulfil their needs without using haemoglobin-
bound oxygen [5].
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The fat-soluble material does not need to pass through pores but reaches tissue directly by 
passing through endothelial cells. Water and water-soluble material use the pores between 
endothelial cells to diffuse and pass into the cell. For diffusion rate, the size of the molecule to 
be diffused is important (Figure 2).
With the Donnan effect, negatively charged proteins responsible for oncotic plasma pressure 
may attach to glycocalyx structures due to charge; however, they cannot bind, and plasma 
oncotic pressure remains high [6].
Mean values Hydrostatic pressure mm Hg
Capillary 17
Interstitial −5.3




Subtotal (positive = outwards) −22
Total (positive = outwards) 0.3
Arterial end Hydrostatic pressure
Capillary 30
Interstitial −5.3




Subtotal (positive = outwards) −22
Total (positive = outwards) 13.3
Figure 2. Diffusion according to the size and solubility of material.
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Forces controlling fluid transfer in capillaries were defined by Starling. While capillary pres-
sure (Pc) and interstitial fluid oncotic pressure (πif) ensure water and solutes leave the vein, 
plasma oncotic pressure (Pπ) and interstitial hydrostatic pressure (Pif) attempt to prevent 
water and solute transfer in the interstitial area. In conclusion, net filtration pressure (NFP) 
develops as NFP = Pc−Pif−π P + πif. The pressure distribution is shown in Table 1.
According to the Starling equation, there is 0.3 mmHg net outward pressure for 2 ml/min 
outward flow. The difference is removed from the interstitial area by the lymphatic system. 
Filtration occurs in the arteriole sections of the capillaries. Fluid reabsorption is clear at the 
venule tips [3].
Lymphatic capillaries include endothelial flaps, and these flaps prevent reverse leakage of 
fluid. Fluid flow is ensured by skeletal muscle contractions with flow rates in the interval 
4–150 ml/hr. Interstitial fluid pressure and lymph fluid rate determine lymphatic flow.
2. Microcirculation regulation
In eukaryotes, transfer of oxygen and nutrition into the cell and removal of carbon dioxide 
and waste material occurs at the cell surface. In multicellular organisms, this event occurs in 
the interstitial area [3].
In humans, blood flow follows the path: left ventricle  large- and medium-diameter arteries 
 small arteries known as precapillary resistance arterioles and terminal arterioles  capil-
lary beds not containing contractile elements and where oxygen and solute exchange occurs 
 postcapillary resistance venules and collecting veins  capacitance veins and large veins 
 right atrium.
Tissue oxygenation (DO2) is calculated as being equal to arterial oxygen saturation (SaO
2
) × 
blood haemoglobin level cHb × 1.39 × cardiac output (CO).
The result is that it takes 30–60 s for oxygen entering blood in the lungs to reach tissues. 
However, for oxygen to reach peripheral tissues, it is necessary for there to be sufficient 
Venous end Hydrostatic pressure
Capillary 10
Interstitial −5.3




Subtotal (positive = outwards) −22
Total (positive = outwards) −6.7
Table 1. Pressure distribution in microcirculation.
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airway opening, normal respiratory pattern, normal alveolar gas exchange, sufficient blood 
haemoglobin level, and sturdy and sufficient vein structure in addition to microcirculatory 
blood flow supplying metabolic requirements of the tissues [7].
For metabolism and sufficient adenosine triphosphate (ATP) production to occur, tissues need 
to have sufficient blood perfusion. In situations without sufficient oxygen supply, anaerobic 
glycolysis increases in tissues and lactic acid release occurs. Increased lactic acid causes meta-
bolic acidosis. Acidosis reduces cardiac contractility and increases peripheral vascular resis-
tance and, as a result, tissue hypoxia deepens. At the same time, increasing blood potassium 
levels linked to developing acidosis reduce cardiac contractility and cause a reduction in the 
presentation of oxygen to tissues.
Apart from true arteriovenous shunt areas of the body, blood perfusion passes through many 
capillary veins, and capillary blood flow is controlled by arteriole resistance. This situation 
is more pronounced especially in the heart, lungs, and skeletal muscles. In situations when 
reduced blood flow reduces in tissues, regional vasodilatation may ensure sufficient blood 
perfusion of tissues and sufficient oxygenation [8].
Moving away from the arteriolar areas, smooth muscle structure begins to appear in the 
adventitia layer of veins. This smooth muscle structure is contracted by adrenergic stimuli 
and is considered to increase capillary perfusion pressure [3].
Vasoconstriction in hyperoxic situations is an attempt to keep tissue oxygenization stable 
and, in addition, to reduce the risk of tissue hyperoxygenization [9]. The 2.5 atmosphere 
pressure applied during hyperbaric oxygen treatment increases 4–5 times partial oxygen 
pressure in subdermal healthy and infected tissues by [10]. In a study, hyperbaric oxygen 
administration had reduced local blood circulation about 76.5% in pancreatitis patients, 
while this rate was identified as 37% with normobaric hyperoxygenization [11]. Hyperoxic 
situations increase oxygen amount, which dissolves in plasma. The free oxygen amount is 
an important point in the development of oxygen diffusion. There is a moderate level of 
oxygen saturation values measured in the postcapillary section of microcirculation. This 
effect may be explained by the vasoconstriction which occurs with the hyperbaric oxygen 
administration.
During inflammation increased leukocyte adhesion occurring in venules and resistance 
increase to venous blood flow develops and venous pressure increases. At the same time, an 
increase occurs in the length of venules. An attempt is made to increase oxygen presentation 
to tissues [12, 13]. Also during inflammation, mediators like vascular endothelial growth fac-
tor (VEGF) are released to the environment and have a venodilatatory effect.
Arterioles and terminal arterioles cause changes in local blood perfusion resistance and may 
directly change the blood flow amount to tissues. In situations with vasodilatation of arte-
rioles and terminal arterioles, there is an opening of closed capillaries and lengthening of 
capillaries. This situation causes an increase in the surface necessary for material transfer. 
However, in situations with venular contraction, there is a hydrostatic pressure increase in 
capillary beds and diffusion pressure increases. Capacitance and large veins change cardiac 
output above the heart’s full volume and affect microcirculation (Figure 3).
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As described by Bayliss, in situations with increased blood pressure, an attempt is made to 
keep blood flow to vital organs like the brain, heart, kidneys, liver, and carotid bodies fixed 
via developing vasocontraction [14]. This adaptation is processed in reverse in hypotensive 
situations. In this development, the tension-sensitive sodium and calcium channels play a 
role.
2.1. Factors affecting arteriole resistance
• Autonomous nervous system (cholinergic, adrenergic, non-cholinergic, non-adrenergic 
system)
• Vasoactive humoral and tissue factors (angiotensin II, bradykinin, vasopressin, catechol-
amines, natriuretic peptides, etc.)
• Local metabolic changes (partial oxygen pressure [PO2], partial carbon dioxide pressure 
[PCO2], pH, osmotic pressure [Posm], potassium [K+] concentration, metabolic material 
like adenosine)
In endothelial tissue, the friction caused by blood triggers nitric oxide (NO) release. In situa-
tions with vasodilatation in NO terminal arterioles, increasing NO release develops. Friction-
linked vasodilatation is responsible for mechanoconduction of the glycocalyx structure 
covering the endothelial surface and plays a role in blood flow regulation in inflammation, 
ischemia and other pathological situations [15].
Vasodilators like NO and prostaglandin I2 are found in the whole vascular system, especially 
the terminal arterioles. Other vasodilator effect agonists include serotonin, histamine, adenos-
ine triphosphate (ATP), adenosine diphosphate (ADP), bradykinin, acetylcholine, thrombin, 
and endothelin.
Figure 3. Local vasodilatation with tissue metabolites. KATP, ATP-dependent potassium ion channel; KIR, inward-rectifying potassium ion channel that gives rise to hyperpolarization; TRPV, transitory receptor-mediated potential; 
cAMP, cyclic adenosine monophosphate.
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NO formed by the nitric oxide synthase enzyme found within endothelial cells is effective through 
paracrine routes. NO within the cell commonly shows the effect by ensuring calcium entry into 
the cell via guanosine monophosphate and protein kinase activation. In addition to vasodilata-
tion, NO has anti-thrombogenic effects by reducing tissue factor expression, platelet aggregation, 
and adhesion molecule expression like VCAM. At the same time, proliferation in venous smooth 
muscles is reduced and it limits neointimal hyperplasia development in vein walls [16].
As a result of material like adrenalin, thrombin, and angiotensin II binding to receptors found 
in abluminal vascular smooth muscle cells, calcium entry into the cell is activated and due to 
the inositol triphosphate (IP3) pathway, endothelin released into the subendothelial intersti-
tial areas causes the better-known vasoconstriction effect [17]. In situations where vasodilator 
materials pass through endothelial cells with increased permeability outside of the vein, the 
vasodilator effect reverses and may cause vasoconstriction.
Specific receptor expression available in endothelial and smooth muscle tissue found in the 
vein structures of organs affect agonist concentration and provide vasoactive material to 
luminal and abluminal vein structures affecting the concentration or dilatation response [3].
In 1922, August Krogh et al. first defined vasodilatation occurring due to the chemical stimu-
lus. In 1971, Siggins and Weitsen showed that vasodilatation was caused by cholinergic stim-
ulation. Khayutin et al. in 1991 showed that vasodilatation occurred due to myelin nerve 
stimulus. In 1959, Hilton showed that communication present between the smooth muscle 
cells found in the vascular walls was effective on vasodilatation.
Gap junctions are structures formed by two half channels completing each other with nearly 
9 nm size, allowing transfer between cells of ions and molecules with weight lower than 
1 kDa isolated from the extracellular environment and linking two neighbouring cells. Just 
as gap junctions form between the same type of cells (endothelium-endothelium, smooth 
muscle-smooth muscle, etc.), they may also form between different cells (myoendothelial gap 
junctions). The channels allow transfer between cells of electrical stimuli and calcium [18].
Each half of gap junctions found in vein structures contain six connexins (Cx) proteins (Cx39, 
Cx40, Cx43, Cx45) [19]. Each connexin protein has effects with different clinical results [20].
In development-linked vasodilatation, each agonist has a different effect mechanism, with 
the best-described effect mechanism belonging to the agonist acetylcholine. When acetylcho-
line binds to a G protein-dependent muscarinic receptor, inositol triphosphate phosphory-
lation develops causing calcium release from endothelial endoplasmic reticulum [21, 22]. 
Simultaneously, calcium-dependent potassium channels open leading to hyperpolarization 
development in the cell [23]. After this flow, vasodilatation develops causing closure of volt-
age-dependent calcium channels within endothelial and vein smooth muscle cells [24]. At the 
same time, ion flows are communicated between cells via gap junctions with vasodilatation 
spreading distal and proximal to the point of acetylcholine binding [2].
Pericytes found in venules have regulatory effects on proliferation, differentiation and contrac-
tility of endothelial cells. During new vein creation, in situations where the endothelial layer 
is developing with tube shape contacts pericytes, endothelial growth and proliferation are 
suppressed, and maturation of the endothelial basal membrane structure is ensured [25, 26].
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In situations with low oxygen levels or pH, ATP molecules released from erythrocytes found 
in microcirculation cause vasodilatation while haemoglobin molecules occurring with eryth-
rocyte fragmentation bind to NO causing the development of NO-dependent vasodilatation.
During hyperoxia the reactive oxygen radicals prevent nitric oxide-mediated vasodilatation; 
on the other hand, vascoconstrictor effect results in low tissue blood flow [27]. In addition, 
synthesis of the vasodilator prostaglandin is reduced while synthesis of the vasoconstrictor 
prostaglandin (and endothelin-1) is increased [28].
3. Methods to assess microcirculation flow
The microcirculation performs the necessary oxygen distribution to meet the basic metabolic 
requirements of the tissues. Anatomically, it consists of arterioles, capillaries and venules. In 
situations where physiological or pathological stress develops, the balance between oxygen 
delivery and demand becomes very important. This delicate balance can play an important 
role in the progression of critical illnesses. In daily clinical practice, monitoring the microcir-
culation is essential for detection of potential organ dysfunctions. The ideal technique would 
allow quantification of vascular recruitment and the magnitude, heterogeneity, responsive-
ness, and efficiency of oxygen transfer to the tissues. There are a variety of methods and 
parameters available to evaluate the microcirculatory state of a patient.
4. Assessment of microcirculation
The assessment of these factors can be analysed in five parameters: (i) total microvascular den-
sity (TVD), (ii) perfused microvascular density (PVD), (iii) proportion of perfused microves-
sels (PPV), (iv) microvascular flow index (MFI) and (v) heterogeneity of microvascular flow 
index. The first two reflect density, (iii) and (iv) reflect the flow, and (v) represents the het-
erogeneity of flow. Microcirculatory blood flow can be detected at the bedside by videomi-
croscopic techniques, and by laser Doppler flowmetry, near-infrared spectroscopy (NIRS), 
tissue reflectance spectrophotometry, or by tonometry. These techniques provide simple and 
quantitative data. Biochemical parameters that show microcirculation are reliable and include 
lactate, tissue CO
2
 content and venous oxygen saturation.
5. Direct methods
5.1. Measuring microcirculatory perfusion
Video microscopic techniques involve highly sensitive video microscopes that allow direct 
measurement of capillary density, perfusion and flow dynamics. Video microscopic tech-
niques have shown a correlation between increased mortality in ICU patients [29]. These tech-
niques, which included orthogonal polarisation spectral (OPS), sidestream dark-field (SDF) 
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imaging and incident dark-field (IDF) imaging (CytoCam) provide in vivo visualisation of the 
microcirculation. OPS and SDF imaging have become clinically useless due to the large size, 
motion and pressure artefacts, operator-dependent output, and the need for offline analysis, 
which takes time to produce data.
6. Indirect methods
6.1. Measuring elements of tissue oxygenation
There are quite some methodologies available for estimating or measuring tissue oxygenation 
at the different levels.
Central venous oxygen saturation (ScvO
2
) and mixed venous oxygen saturation (SvO
2
).
They provide knowledge of the patient’s oxygen delivery, oxygen consumption, and cardiac 
output. ScvO
2
 > 70% or SvO
2
 > 65% is recommended for critical patients [30]. SvO
2
 is an adap-





, haemoglobin and cardiac output. Consequently, SvO
2
 (or its surrogate ScvO
2
) is widely 
fluctuating. Thus, when normal, those parameters cannot rule out any impairment in tissue 
oxygenation related to an impaired microcirculation [31].
6.2. Near-infrared spectroscopy (NIRS)
NIRS has been developed as a non-invasive diagnostic tool for measurement of regional hae-
moglobin oxygen saturation in a particular organ. NIRS is mainly used in the evaluation of 
cerebral oxygenation in cardiac, non-cardiac surgery and traumatic intensive care patients. 
The NIRS signal is restricted to vessels that have a diameter of less than 1 mm, and this tech-





mostly describes the saturation of all vessels, while total tissue haemoglobin (HbT) and the 
tissue haemoglobin index (THI) indicate the amount of blood present in the tested region. 
Brain venous blood is primarily responsible for a decrease in brain saturation and predomi-
nantly results from a local increase in oxygen extraction. During haemorrhage the arterial 
component preserved while venous part decreases markedly. On the other hand, in trauma 
patients, StO
2
 is altered only in the severe cases and in other forms show low sensitivity [33]. 
NIRS-derived dynamic measurements (vaso-occlusive test, VOT) demonstrated profound 
alterations in microvascular reactivity. The NIRS technique is done for a brief episode of fore-
arm ischemia induced by transient inflation of a cuff determines changes in StO
2
. Some indi-
ces can be measured during this test, but the most important is the ascending slope reflecting 
microvascular reactivity. The severity of these alterations in microvascular reactivity is associ-
ated with organ dysfunction and mortality [34].
6.3. Tissue CO
2
 (gastric tonometry, veno-arterial CO
2







) has been measured in the stomach, sublingual area, and earlobe. Tissue 
PCO
2




, and tissue blood flow. Normally, an increase 
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is constant, and PtCO
2
 is increased, there is an inadequate relationship between metabolism 




 gap) <7 mmHg. Elevated 
PCO
2
 gaps may signify either flow stagnation or tissue hypoxia [35]. Importantly, there is an 





represents a good assessment of tissue perfusion.
Microcirculatory alterations in critically ill patients may play a role in the development of 
organ dysfunction. Video microscopic techniques and tissue PCO2 measurements can be 
used to evaluate microvascular perfusion. But, microcirculation monitoring is not yet part of 
routine clinical practice.
6.4. Lactate
Lactate in the human body is a metabolic product of anaerobic glycolysis, produced from the 
reduction of pyruvate by the enzyme lactate dehydrogenase, and reflects inadequate oxygen 
delivery. Normally, a total amount of 1500 mmol of lactate is produced daily in adult, and 
blood lactate levels are sustained less than 2 mmol/L. However, in the state of hypoperfusion 
and hypoxia, pyruvate rapidly accumulate, and its metabolism is shifted almost entirely to 
lactate production. The tissue hypoxia is a cause of lactate elevation and characterised by 
supply-dependent oxygen consumption [36]. Single measurement of lactate can only serve 
as a risk-stratification biomarker. Lactate clearance with its association with clinical outcome 
should be used during treatment to make it more clinically useful [37].
6.5. Microcirculation and hyperbaric oxygen therapy
Hyperbaric oxygen therapy (HBOT) is a clinical treatment in which a patient breathes pure 
oxygen for a limited period of time at an increased pressure. This therapy has been suggested 
to improve oxygen supply to tissues and therefore improves microcirculation [38]. HBOT in 
patients with diabetic foot ulcer was associated with a greater reduction in the ulcer wound 
area than standard therapy and significantly improves the ulcers in a short term [39]. Also, 
HBOT which is applied in acute ischemic stroke, femoral head necrosis, and carbon monoxide 
intoxication aims to increase oxygen supply to the ischemic tissue and to reduce the extent of 
irreversible tissue damage [40–42].
7. Microcirculation and disease
7.1. Microcirculatory dysfunction
Microcirculation plays a critical role in the physiological process such as oxygen supply to tissues 
and nutritional exchange and has a key role in modulation of inflammation and coagulation. 
These functions are mainly controlled by endothelial cells, which produce biologic signals to reg-
ulate local blood flow, cell adhesion, permeability, and coagulation activation. The most impor-
tant function of the microcirculation is the regulation of flow within the different organs [43].
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Microcirculation, in general, provides sufficient oxygen distribution to meet the oxygen 
demands of every cell within an organ. A regulatory mechanism with several signalling path-
ways allows microcirculatory flow to occur independently of changes in systemic blood pres-
sure; this mechanism is called autoregulation. Perfusion of capillaries increases due to the 
vasodilation of terminal arterioles, which causes a decrease in the number of recruited capil-
laries. These capillaries are mainly under local control, which is possible because endothelial 
cells sense metabolic and physical signals, and respond to them by modulating arteriolar 
smooth muscle cell tone. In this process, nitric oxide (NO), which is produced by endothelial 
cells, is one of the components in the exertion of this process [44].
In the pathophysiology of sepsis and septic shock, the microcirculation is the basic region 
of the circulatory system, in which main components are arterioles, venules, shunts, and 
capillaries. The structures in the microcirculation system are capable of contraction, except 
capillaries. Capillaries are made of endothelial cells alone, without contractile structures. 
Microcirculatory dysfunction may arise as a result of several factors such as endothelial dys-
function, leukocyte-endothelium interactions, coagulation and inflammatory disorders, and 
functional shunting that may occur during sepsis which can affect capillaries to change hemo-
dynamics [43, 44].
Microcirculatory changes during sepsis include various mechanisms such as redistribution of 
blood flow from the skin and the splanchnic area to brain or heart, or with endothelial activa-
tion and injury which results with the loss of the glycocalyx around endothelium. Increased 
microvascular permeability with capillary damage then causes oedema formation and hypo-
volemia. And also, secondary capillary plugging comes out with decreased RBC deformability 
and increased leukocyte adhesion to the endothelial surface. On the other hand, production 
of reactive oxygen species (ROS) disturbs microcirculatory structures, cellular interactions, 
and haemostasis. Overall, these alterations contribute to a reduction in decreased functional 
capillary density, the progress of various abnormalities in microcirculatory blood flow, and 
the loss of main vasoregulation in most vascular beds. These alterations terminate with a 
disrupted regulation of local oxygen delivery, which turns into the fast initiation of tissue 
hypoxia [44, 47].
Proinflammatory cytokines become dominant in the early stages of sepsis to eliminate the 
pathogen. However, proinflammatory responses in sepsis generate an intense response 
that impairs the microcirculation. In this stage, most of the cellular components of the 
microcirculation, such as endothelial cells, smooth muscle cells, platelets, leukocytes, and red 
blood cells are affected. Increased number of interrupted capillaries results with microcircu-
latory dysfunction which appears to have prognostic significance in sepsis, as the severity of 
initial microcirculatory imbalance in the early resuscitation phase of therapy [45, 46].
In sepsis, NO synthase (iNOS) which heterogeneously expressed in various vascular 
beds, causes pathological shunts. Therefore, iNOS-deficient areas become hypoperfused. 
Furthermore, increased production of reactive oxygen species interferes with NO formation 
by endothelial NOS and with formed NO, reducing its concentration. Also, during sepsis, red 
blood cells lose their ability to release vasodilators in the presence of hypoxia that impairs 
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physiological regulatory mechanism of microcirculation. In that case, red blood cells become 
less deformable and more easily aggregate with endothelial cells during sepsis [47, 49].
During sepsis, the percentage of activated neutrophils with increased adhesion molecules 
generate reactive oxygen species and inflammatory soluble factors that directly disrupt micro-
circulatory structures, such as the endothelial glycocalyx. Oxidative stress causes changes in 
endothelial glycocalyx structure. Permanent glycocalyx degradation leads to loss of integrity 
of adherens junctions and increased paracellular permeability with the following break of 
endothelial barrier function, which results in fluid leakage from the intravascular space and 
causes tissue oedema. Afterwards, accumulation of water in tissues leads to tissue hypoxia.
In sepsis, endothelial glycocalyx degradation is associated with sepsis-related clinical condi-
tions such as acute lung injury and cardiovascular dysfunction as a consequence of microcir-
culation dysfunction. Also, glycocalyx degradation contributes to the enhanced expression of 
adhesion molecules with increased leukocyte trafficking and shift towards the procoagulant 
state. Prothrombotic effect further contributes the adhesion of red blood cells, leukocytes, and 
platelets to the vascular endothelium, which causes vascular microthrombosis. The activation 
of coagulation pathways results in capillary obstruction by fibrin clots secondary to dissemi-
nated intravascular coagulation [44, 47].
7.2. Treatment
The microcirculation is important for the normal delivery of oxygen to vital organs. The type 
and phase of critical illness define the degree of microcirculatory resuscitation required. It is 
important to recruit the microcirculation due to heterogeneous nature of the microvascular 
alterations. Fluid resuscitation and vasoactive agents are one of the main therapies for the 
hemodynamic resuscitation that aims to restore the circulating volume, and increasing the 
cardiac output and arterial blood pressure in shock patients and play a critical role with 
the goal of improving tissue perfusion. Individual responses to vasopressors may change, 
but the microvascular response to vasopressors appears to be dependent on the basal condi-
tion of the microcirculation [50]. Fluid resuscitation improves microcirculatory blood flow. 
The mechanisms by which fluids may improve the microcirculation are not well understood 
but may be related to restoring circulatory volume which increases perfusion pressure and 
causes local vasodilation, or modulates interactions between the endothelium and circulating 
cells to decrease microvascular blood viscosity [46, 48, 49].
Hypertonic saline (HTS) is a potential solution to cure the microcirculation of traumatic 
haemorrhagic shock. HTS improves intestinal perfusion associated with arteriolar vasodila-
tion of distal premucosal arterioles, decreases endothelial oedema and prevents leukocyte 
adhesion to postcapillary venules. To restore capillary density, a new approach to fluid resus-
citation is based on the fluid with high viscosity to increase plasma viscosity and NO produc-
tion causing microcirculatory vasodilation with resulting capillary recruitment. At the same 
time, vasopressor agents may maintain tissue perfusion in the presence of life-threatening 
hypotension in haemorrhagic shock, even if fluid dilatation is in progress and hypovolemia 
has not yet been corrected [49].
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The effects of red blood cell transfusions also seem to be quite variable. One of the other 
commonly used therapy is transfusions of red blood cells (RBC), which is used in criti-
cally ill patients to restore oxygen-carrying capacity. But, transfusion decisions are based 
on serum haemoglobin levels, and it is difficult to notice because normal microvascular 
haematocrit is much lower than systemic values. Although the beneficial effect of RBC trans-
fusions over microcirculatory parameters in septic patients is still not clear, RBC transfu-
sions are effective in improving tissue oxygen transport by promoting RBC delivery to the 
microcirculation [50].
Fluid resuscitation in combination with vasoactive and inotropic support is effective in 
improving the microcirculation. Recruitment of the microcirculation can be achieved with 
combination therapies. An anti-inflammatory agent or specific iNOS inhibitor can reduce 
pathological shunting and improve blood flow to recruit weak microcirculatory units. The 
effects can be seen in the early phase of sepsis, within 24 h of diagnosis, but if cardiac output 
is increased, no improvement will be made after 48 h [51].
The use of steroids in sepsis may provide a clinical benefit in modulating the systemic inflam-
matory response. It can preserve the endothelial glycocalyx and attenuate rolling of leu-
cocytes to the endothelium, may improve endothelial function and thereby ameliorate the 
distributive defect [52].
Statins, which are cholesterol-lowering agents also have pleiotropic effects and have an anti-
inflammatory and anti-oxidant activity during sepsis. They increase levels of eNOS, with the 
down-regulation of iNOS, so this regulation of NOS increases NO levels, restoring the auto-
regulatory functions [53].
Vasodilator substances may have a role to restore the microcirculation and decrease the effect 
of excessive vasoconstriction which causes decreased vascular density and stopped-flow cap-
illaries. In a research, it was reported that nitroglycerin administration rapidly improved the 
microcirculation [54].
In haemorrhagic shock, reducing the blood flow to the microvascular units may prevent 
hypoxia. This downregulation of cellular metabolism is called conformance or hibernation. 
However, increase in lactate level during the acute phase of haemorrhagic shock indicates 
the limits of this adaptative metabolic downregulation. The critical factor in microvascular 
regulation to meet oxygen supply is the local regulation of arteriolar tone. Many mechanisms 
contribute to the local regulation of arteriolar tone, which includes response to myogenic 
response, shear-dependent response, and tissue metabolic response. During haemorrhagic 
shock, the decrease in DO2 reduces the generation of adenosine 5′ triphosphate (ATP) and 
adenosine 5′ diphosphate (ADP) which results in the accumulation of ADP and its degrada-
tion products. CO
2
 is a strong vasodilator, which accumulates when there is an increase in cel-
lular metabolism or reduced clearance of CO
2
 during tissue hypoperfusion. In haemorrhagic 
shock, the therapeutic precedence is to stop the bleeding and to prevent the increase of bleed-
ing. Fluid resuscitation may promote coagulopathy by diluting coagulation factors [55, 56].
Reduced microvascular perfusion is a characteristic feature of sepsis and implicated in organ 
dysfunction with multiple organ failure. Hyperbaric oxygen (HBO) has potentially beneficial 
effects for the microcirculation improvement in sepsis . It was shown that HBOT improves 
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microcirculation independently from systemic hemodynamic parameters which is a key ther-
apeutic target in septic shock patients. [57]. Some of well-documented HBOT mechanisms 
in sepsis treatment are attenuation of inflammatory mediators and free radicals, reduction 
of bacterial proliferation, inhibition of lipopolysaccharide-induced acute lung injury and 
enabling neutrophils to kill bacteria with oxygen dependent mechanisms. It was also pro-
posed that HBOT can delay onset of sepsis and may boost the effect of antibiotics [58].
Meningococcal sepsis can cause purpura fulminans which occurs by the formation of thrombi 
haemorrhages and occlusion of dermal vessels and often a life-threatening condition [59].. 
Clinically, it was shown that HBOT is effective in meningococcal sepsis which is complicated 
with the necrotic tissue [60]. HBOT with its immunostimulatory, neovascularity, and bacteri-
cidal effect can be adjunct treatment for non-healing ulcers and problematic wounds.
8. Conclusion
In conclusion, microcirculation plays a critical role in the physiological process such as oxy-
gen supply to vital organs, nutritional exchange and modulation of inflammation. The most 
important function of the microcirculation is the regulation of flow within the different organs. 
Microcirculatory changes include various mechanisms such as redistribution of blood flow 
from the skin and the splanchnic area to brain or heart, or with endothelial activation and 
injury which results with the loss of the glycocalyx around endothelium. The assessment of 
the microcirculation enables us for the early detection of possible deterioration and potential 
organ dysfunctions. Microcirculatory blood flow can be detected at the bedside by different 
techniques which are simple and gives quantitative data. Fluid resuscitation and vasoactive 
agents are one of the main therapies for the hemodynamic resuscitation that aims to restore 
the circulating volume, and increasing the cardiac output and arterial blood pressure and play 
a critical role with the goal of improving tissue perfusion. HBOT inhibits replicating, spread-
ing of anaerobic and some other bacteria and is a clinical treatment adjunct to traditional sur-
gery and antibiotic therapy for the deadly serious necrotizing infection. Also, HBOT applied in 
acute ischemic stroke, femoral head necrosis and carbon monoxide intoxication aim to increase 
oxygen supply to the ischemic tissue and to reduce the extent of irreversible tissue damage.
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